Expert Interview
Discussing the Phase 3 results for ENHERTU (fam-trastuzumab deruxtecan-nxki) presented at the recent ASCO Conference.
Ticker(s): AZNDr. Kimberly Ku - MD
- Treats about 30 patients per month with Pneumococcal Disease
- Internal Medicine, Hematology Oncology with Illionois CancerCare
Dr. Ku is a general hematologist oncologist in the community setting currently seeing patients in central Illinois. In addition to treatment of disorders of all tumor types and blood disorders, Dr. Ku is also often consulted by multidisciplinary caretakers for questions related to preventative health such as vaccination schedules, cancer screenings, and genetic testing.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
